scholarly journals NeuroAid II (MLC901) in Haemorrhagic Stroke

2020 ◽  
Vol 12 (Suppl. 1) ◽  
pp. 212-217
Author(s):  
Chai-Hoon Nowel Tan ◽  
David Choy ◽  
Narayanaswamy Venketasubramanian
Keyword(s):  
Stroke Risk ◽  
Haemorrhagic Stroke ◽  
Stroke Recovery ◽  
Stroke Risk Factor ◽  
Thalamic Haemorrhage ◽  
Hypertensive Therapy ◽  
Serial Brain ◽  
Field Defect ◽  
Unilateral Weakness ◽  
Intensive Rehabilitation

Stroke is a leading cause of death and disability. NeuroAid (MLC601), which originates from Traditional Chinese Medicine, comprises herbal and animal components, and has been shown to improve the functional status of patients after ischaemic stroke. The use of NeuroAid II (MLC901), which comprises only the herbal components of MLC601, in haemorrhagic stroke has not been previously reported. Our patient is a 63-year-old male with a significant stroke risk factor of hypertension. He developed visual field defect, aphasia, unilateral weakness, and hemisensory loss. CT scan showed a left thalamic haemorrhage. In addition to anti-hypertensive therapy and intensive rehabilitation, he was prescribed MLC901. Over a period of 6 months, he had significant improvements in his motor, sensory, and speech function. There were no adverse events, serial brain CT scans showed resolution of the haemorrhage. MLC901 may have a role in post-stroke recovery after intracranial haemorrhage.

scholarly journals Prevalence, Impact, and Treatment of Co-Occurring Osteoarthritis in Patients With Stroke Undergoing Rehabilitation: A Review

Stroke ◽  
2021 ◽  
Author(s):  
John Fournier ◽  
Hillel Finestone ◽  
Julia Lauzon ◽  
T. Mark Campbell
Keyword(s):  
Risk Factor ◽  
Stroke Risk ◽  
Treatment Options ◽  
Stroke Recovery ◽  
High Quality Research ◽  
Stroke Risk Factor ◽  
Risk Factor Management ◽  
Function Management ◽  
The Impact

Background and Purpose: Early, frequent rehabilitation is an important factor for optimizing stroke recovery outcomes. Medical comorbidities, such as osteoarthritis, that affect the ability to participate in rehabilitation could therefore have a detrimental impact on such outcomes. Both stroke and osteoarthritis are becoming more common in developed nations as the population ages. First-line osteoarthritis treatments, such as oral nonsteroidal anti-inflammatory drugs, are often avoided poststroke due to interaction with secondary prevention stroke risk-factor management. Our objective was to summarize the current literature concerning co-occurring osteoarthritis and stroke prevalence, its functional impact, and treatment options. Methods: Narrative review using a comprehensive literature search of PubMed, osteoarthritis, and stroke guidelines. Outcomes related to co-occurrence prevalence, osteoarthritis as a stroke risk-factor, osteoarthritis-related imaging and treatment were extracted and summarized descriptively. Overall quality of the evidence was summarized using Grading of Recommendations Assessment, Development and Evaluation. Results: We identified 23 studies and guidelines related to our objective. Overall quality of the evidence was very low. Conclusions: Few trials have investigated the relationship between osteoarthritis and stroke, nor osteoarthritis-specific pain and function management for stroke survivors. High-quality research evaluating the impact of osteoarthritis on stroke rehabilitation is needed.

Abstract W P386: Matrix Metalloproteinase Levels May Mediate Ischemic Stroke Incidence and Recovery in Stroke Patients with Metabolic Syndrome

Stroke ◽  
2015 ◽  
Vol 46 (suppl_1) ◽  
Author(s):  
Ashley B Petrone ◽  
Taura L Barr ◽  
Kelly Devlin ◽  
Sara B Fournier ◽  
Evan D Devallance ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Stroke Risk ◽  
Plasma Concentrations ◽  
Stroke Recovery ◽  
Ultrasound Images ◽  
Stroke Patients ◽  
Stroke Incidence ◽  
The Metabolic Syndrome ◽  
Diabetes Status ◽  
Increased Risk

Intro: The metabolic syndrome (MetS) is highly prevalent in the US characterized by a combination of risk factors that can lead to cardiovascular disease (CVD). While the association between CVD, inflammation, and stroke risk has been characterized, the immune mechanisms underlying increased risk of stroke in MetS is unclear. While stroke risk is higher among MetS, MetS individuals tend to have better stroke recovery than controls. The immune response may mediate these paradoxical observations in stroke. In particular, matrix metalloproteinases (MMP) enzymes play a role in stroke incidence and recovery. Similar to MetS, MMPs have a dual role in stroke, as they are harmful immediately after stroke, but play a vital role in brain repair and recovery following stroke. We hypothesize that elevated levels of MMPs in MetS may account for the paradoxical increased stroke risk, yet better recovery seen in stroke patients with MetS. Methods: MMP protein concentrations were obtained from fasting venous samples and quantified using a Multi-Analyte Profiling Kit (Millipore) on the Luminex®. Each subject was assigned a metabolic risk score (MRS) based on sex, age, SBP, treatment for hypertension, smoking and diabetes status, HDL, and total cholesterol. B-mode ultrasound images of the right common carotid artery were obtained to measure intima-medial thickness (cIMT). Spearman correlations were used to measure the relationship between MRS, cIMT, and MMP levels. Results: In n=68 subjects (60% female) with a mean age of 48+14 yrs, MRS of 25+12, and cIMT of 0.57+0.12 mm. MRS was significantly correlated with cIMT (r=0.39, p< .001). Further, cIMT was positively correlated with MMP1 (r=0.025, p=0.04), MMP7 (r=0.5, p=0.01), and MMP9 (r=0.31, p=0.01). Conclusion: Plasma concentrations of MMP1, 7, and 9 were significantly correlated with cIMT, indicating that increased severity of MetS is associated with increased inflammation. Elevated MMP protein levels may account for the increased stroke risk, yet better recovery seen in stroke patients with MetS.

Abstract WP328: A Nurse-Led Initiative Improves Adherence Rates for Stroke Follow-up and Blood Pressure Management

Stroke ◽  
2013 ◽  
Vol 44 (suppl_1) ◽  
Author(s):  
Darren T Larsen ◽  
Helmi L Lutsep
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Stroke Prevention ◽  
Stroke Risk ◽  
Retention Rates ◽  
Matched Cohort ◽  
Stroke Patients ◽  
Stroke Risk Factor ◽  
Chi Square Analysis

Background and Issues Aggressive management of vascular risk factors reduces stroke rates. It is unknown whether structured nurse-led follow up increases adherence rates for stroke patients after hospital discharge. Purpose The purpose of this program is to improve secondary stroke risk factor management by instituting a nurse-led initiative called Stroke Therapy, Education, Prevention (STEP). Methods The pilot STEP program was based on protocols used for other stroke prevention trials. This nurse-led program includes inpatient initiation and outpatient maintenance of pharmacologic and lifestyle goals for stroke patients. Eligible patients have a non-disabling ischemic stroke or TIA and are without insurance restrictions and live within a distance allowing return to clinic for follow up. Prior to discharge, the STEP nurse completes patient education, and reviews outpatient goals. The STEP nurse makes phone contact with the patient 7-10 days after discharge to review medication compliance and reinforce education. At 30 days post discharge patients are seen in clinic by the STEP nurse where a resting blood pressure (BP) is measured. If the patient does not meet targets (<140 SBP or <130 SBP for DM) medications are adjusted by a stroke neurologist. We undertook a retrospective chart review of a consecutive cohort of patients matched to STEP eligibility criteria to determine whether the program improved retention rates and BP management. Chi-Square analysis was used to compare visit adherence and percentage achieving goal BPs at 30 days. Results In the STEP group 25/32(78%) patients completed the 30 day follow up compared to 14/32 (44%) patients in the historical matched cohort (p=0.0048). Target BP was achieved in 13/25(52%) STEP patients and 5/14 (36%) matched cohort patients (p=0.32) returning to clinic. Overall, target BP was achieved in 13/32 (41%) and 5/32 (16%) respectively (p=0.026). Conclusions In conclusion, follow up adherence and BP management in the group as a whole was better in the nurse-led model and is recommended for secondary stroke prevention. Long term follow up with this model may further increase in-target rates of BP control and other stroke risk factors.

Abstract WP345: Stroke Risk Factors Screening and Education: A Regional Strategy to Address Stroke Prevalence and Mortality in Eastern North Carolina

Stroke ◽  
2013 ◽  
Vol 44 (suppl_1) ◽  
Author(s):  
Terry M Congleton ◽  
Cristine W Small ◽  
Susan D Freeman
Keyword(s):  
Risk Factors ◽  
North Carolina ◽  
Stroke Risk ◽  
Stroke Mortality ◽  
Transient Ischemia ◽  
Stroke Risk Factor ◽  
Stroke Risk Factors ◽  
Regional Collaboration ◽  
Stroke Prevalence ◽  
Eastern North Carolina

Background: Eastern North Carolina (ENC) stroke mortality is 12 percent higher than the rest of the state. Often, geographical and sociological barriers prevent people residing in our rural communities from seeking routine health care. Stroke risk factors are known. The purpose of this initiative is to reduce the stroke prevalence and mortality in ENC through community risk factors screening and education. Methods: Medical center volunteers’ staff the screening and volunteer hours are recorded in a community benefit database. Each participant completes a standardized evidenced based assessment. Information collected at each screening includes demographic data, cardiovascular history, knowledge of stroke/transient ischemia signs and symptoms. Clinical metrics obtained are finger stick for random lipid panel and blood glucose, body mass index, hip to waist ratio and carotid bruit screen. Based on the screening results, education, recommendations and referrals are reviewed with every participant. Results: From 2007-2010 the screening volume doubled. In 2011, there was a reduction in screening volume as our system hospitals expanded their community stroke outreach efforts. Approximately 4900 community screenings have been conducted from 2007-2011. Elevated blood pressure and cholesterol respectively are most frequently occurring stroke risks factor found, which is consistent with national trends. Stroke mortality has decreased in the region while transient ischemia attack admissions volume has increased at our certified primary stroke center and regional referral center. Conclusions: In conclusion, primary and secondary prevention through community outreach education, risk factors screening and regional collaboration has made a difference. The region has seen a decrease in stroke prevalence and mortality in ENC. Further reduction is necessary to continue to make an even greater impact. Future directions for the stroke risk factor identification screening is to further integrate community efforts and seeks grant opportunities to establish stroke prevention and management clinics throughout the region.

Abstract TP31: Atrial Cardiopathy: Incidence in Endovascular Thrombectomy Patients

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Katerina D Arvanitakis ◽  
Jason Wenderoth ◽  
Andrew Cheung ◽  
Khalid Alsahli ◽  
Alessandro Zagami ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Stroke Risk ◽  
P Wave ◽  
Large Vessel Occlusion ◽  
Vessel Occlusion ◽  
Stroke Risk Factor ◽  
Endovascular Thrombectomy ◽  
P Wave Duration ◽  
Total Cohort ◽  
Electrocardiogram Ecg

Background: Emerging evidence suggests that underlying atrial cardiopathy (AC) may result in thromboembolism formation in the absence of atrial fibrillation (AF). This may explain a proportion of large vessel occlusion (LVO) cryptogenic strokes. The prevalence of AC in endovascular thrombectomy (EVT) patients has not been assessed. Methods: A prospectively maintained database of EVT patients treated at a comprehensive stroke centres between January 2016 and September 2018 was retrospectively screened. Patients undergoing EVT for acute ischemic stroke with admission electrocardiogram (ECG) were selected. Subjects were screened for AF, paroxysmal AF (pAF) and AC with previously validated ECG markers (P-wave terminal force in lead V1 - PTFV1 >4000μV/ms & prolonged P-wave duration - PWD >120 ms. Results: A total of 189 patients were included. Atrial fibrillation was present in 73 (38.6%) patients. Paroxysmal AF was recorded in 31 (16.4%) patients. Atrial cardiopathy markers were present in 88 (46.6%) of the total cohort, compared to 7.7% in a published general population reference (p < 0.001). Atrial cardiopathy was present in 23 (74%) of pAF patients. Conclusion: Atrial cardiopathy occurs frequently in EVT patients, suggesting it may be a LVO stroke risk factor. Atrial cardiopathy may be associated with pAF. Further studies in this patient population are recommended.

Abstract T P95: Coronary Artery Disease in Moyamoya Disease

Stroke ◽  
2014 ◽  
Vol 45 (suppl_1) ◽  
Author(s):  
Kyung Il Jo ◽  
Jong Soo Kim ◽  
Seung-Chyul Hong ◽  
Je Young Yeon
Keyword(s):  
Coronary Artery Disease ◽  
Risk Factor ◽  
Coronary Artery ◽  
Moyamoya Disease ◽  
Stroke Risk ◽  
Bypass Graft ◽  
Coronary Artery Lesion ◽  
Conventional Coronary Angiography ◽  
Stroke Risk Factor ◽  
Artery Disease

Background and Purpose: Coronary artery disease in moyamoya disease (MMD) have been described sporadically in several case reports. The purpose of this study is to determine the prevalence and characteristics of coronary artery disease in patients with MMD. Methods: From August 1991 to December 2012, 446 patients diagnosed with adult MMD at our hospital. Baseline characteristics and prevalence of coronary artery disease were reviewed based on medical records and laboratory findings. The findings of conventional coronary angiography and/or coronary computed tomography were also reviewed for the presence and appearance of coronary artery lesion. Results: - Of 446 patients with adult MMD, 21 patients were found to have coronary artery disease. Ten patients were treated with coronary artery bypass graft (n=4) or percutaneous coronary intervention (n=6) for unstable angina or myocardial infarction. Eleven were treated with medication for stable angina (n=6) and variant angina with mild degree of stenosis (n=5). Median age at diagnosed with coronary artery disease of these patients were 44 (range, 27-59). Two patients showed calcification on coronary artery lesion. Comorbid stroke risk factor rate were 19%, 38%, 9.5% and 19 % in diabetes, hypertension, dyslipidemia and smoking. Six of 21 patients had more than 2 risk factor. Conclusion: - Twenty one (4.7%) of our adult MMD registry patients showed coronary artery disease. And only 2 (9.5%) showed calcification which might means that atherosclerosis burden is low in coronary artery disease with MMD. Coronary artery disease might be a clinically relevant systemic manifestation in patients with MMD, considering early onset coronary diseaes and low prevalence of stroke risk factor.

scholarly journals Epidemiologica and factors risk of stroke in Kemerovo

2008 ◽  
Vol 7 (5-1) ◽  
pp. 170-174
Author(s):  
A. V. Kovalenko ◽  
O. A. Gileva
Keyword(s):  
Risk Factor ◽  
Arterial Hypertension ◽  
Epidemiological Study ◽  
Stroke Risk ◽  
Cerebrovascular Disorders ◽  
Stroke Risk Factor ◽  
Cardiac Pathology ◽  
Prospective Epidemiological Study ◽  
Close Relatives

The paper presents the results of the first prospective epidemiological study of stroke in Kemerovo. The stroke was primary in 77,1% patients, the second one was in 22,9% patients. The frequency of the development of stroke increased with the years. The most prevalent risk factor was arterial hypertension which was recorded in 91,6% patients. Cardiac pathology as a stroke risk factor ranked second (61,7%). Cerebrovascular disorders in close relatives were registered in 55,5% patients. One-month lethality was 41,1%.

Sign in / Sign up

Export Citation Format

Share Document